
ESTA Stock Forecast & Price Target
ESTA Analyst Ratings
Bulls say
Establishment Labs Hldgs is a leader in the medical technology industry, specifically in silicone breast implants, with increasing demand and potential market expansion through product developments and minimally invasive surgery techniques. Despite potential risks from competition and regulations, the company has a strong financial performance and a projected positive outlook for the coming years, specifically in the minimally invasive business and planned product expansions.
Bears say
Establishment Labs Hldgs is seeing a continued increase in Motiva usage, driven by factors such as growing patient demand, increased familiarity and positive outcomes from physicians, and long-term safety data. As a result, it is expected to capture a significant share of the market from competitors such as Allergan and Mentor. Their continuous improvement in surveys and increased number of accounts shows promising growth potential, justifying a Buy rating and a $90 price target. Risks include economic downturn, competition, and potential complications, among others.
This aggregate rating is based on analysts' research of Establishment Labs Holdings Inc and is not a guaranteed prediction by Public.com or investment advice.
ESTA Analyst Forecast & Price Prediction
Start investing in ESTA
Order type
Buy in
Order amount
Est. shares
0 shares